A randomized-controlled trial of an early minimal cognitive-behavioural therapy for insomnia comorbid with cancer
A randomized-controlled trial of an early minimal cognitive-behavioural therapy for insomnia comorbid with cancer
复制标题
DOI:
10.1016/j.brat.2015.02.003
复制
发表时间:
2015-04-01
影响因子:
4.1
通讯作者:
Savard, Marie-Helene
中科院分区:
文献类型:
--
作者:
Casault, Lucie;Savard, Josee;Savard, Marie-Helene
Objective: This study aimed to provide preliminary evidence on the efficacy of an early minimal cognitive-behavioural therapy for acute insomnia (mCBT-I) comorbid with cancer.Method: Thirty-eight patients (92% female; M-age 57; all Caucasian) with various types of cancer and having insomnia symptoms for less than 6 months were randomized to a self-administered mCBT-I condition (n = 20; 6 short booklets + 3 phone consultations with a psychologist, over 6 weeks) or a no-treatment condition (n = 18). Measures were completed at pre-treatment and post-treatment, as well as at 3- and 6-month follow-ups.Results: All sleep parameters and the average dosage of hypnotics were significantly improved from pre- to post-treatment among treated participants, but not in control participants. mCBT-I was also associated with a significantly greater reduction of anxiety and depression symptoms, maladaptive sleep habits, and erroneous beliefs about sleep, as well as with a significantly greater improvement of subjective cognitive functioning. A greater proportion of mCBT-I participants than controls met the criteria for a clinical remission at post-treatment. Therapeutic gains of mCBT-I were well sustained up to 6 months after the intervention.Conclusions: This study supports the efficacy of an early minimal CBT-I to treat acute insomnia comorbid with cancer. (C) 2015 Elsevier Ltd. All rights reserved.